Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IPIX | US
-0.00
-50.00%
Healthcare
Biotechnology
30/09/2023
09/03/2026
0.00
0.02
0.02
0.00
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
1426.7%1 month
1554.9%3 months
1396.2%6 months
2679.1%-
-
0.45
0.20
0.04
-1.08
202.69
-
-1.99M
259.17K
259.17K
-
-
-
-
-114.34
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.02
Range1M
0.02
Range3M
0.02
Rel. volume
0.41
Price X volume
33.55
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ZVSA | ZVSA | Biotechnology | 0.2301 | 247.17K | -11.50% | 0.00 | 0.00% |
| Windtree Therapeutics Inc | WINT | Biotechnology | 0.01 | 36.80K | -25.93% | n/a | 36.99% |
| Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0.0001 | 12.68K | n/a | 113.12% | |
| Syros Pharmaceuticals Inc | SYRS | Biotechnology | 0.0002 | 5.36K | 0.00% | n/a | -954.99% |
| EFTR | EFTR | Biotechnology | 0.0002 | 940.83 | n/a | 2315.36% | |
| XOMAP | XOMAP | Biotechnology | 25.885 | 0 | 0.45% | 26.27 | 121.93% |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.3 | 0 | -0.49% | 25.57 | 121.93% |
| SABSW | SABSW | Biotechnology | 0.0318 | 0 | 0.17 | 11.58% | |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 1.83 | 0 | 1.67% | n/a | 5.40% |
| REVBW | REVBW | Biotechnology | 0.0091 | 0 | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.08 | 0.53 | Cheaper |
| Ent. to Revenue | 202.69 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.45 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1,396.19 | 72.80 | Riskier |
| Debt to Equity | 0.20 | -1.23 | Expensive |
| Debt to Assets | 0.04 | 0.25 | Cheaper |
| Market Cap | 259.17K | 3.66B | Emerging |